IEX Stock Recent News

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.

Reference is made to the stock exchange notice from IDEX Biometrics ASA on 21 May 2025 regarding the subscription period (the "Subscription Period") in the subsequent offering (the "Subsequent Offering") consisting of up to 600 million new shares at a subscription price of NOK 0.01 per share (“Offer Shares”).

IEX is set to benefit from the solid momentum across its FSDP & FMT segments. However, increasing expenses remain a concern.

CHICAGO--(BUSINESS WIRE)--Littelfuse, Inc. (NASDAQ: LFUS), a leader in developing smart solutions that enable safe and efficient electrical energy transfer, today announced that Abhi Khandelwal has been appointed Executive Vice President and Chief Financial Officer, effective June 18, 2025. Mr. Khandelwal brings more than 20 years of financial and operational experience to Littelfuse, most recently serving as Executive Vice President and Chief Financial Officer at IDEX Corporation (NYSE: IEX).

IDEX Biometrics ASA held the annual general meeting on 21 May 2025.  All resolutions were passed as proposed in the notice and agenda update for the meeting.

In connection with the first quarter 2025 report released earlier today, IDEX Biometrics CEO Anders Storbråten will host a presentation at Arctic Securities at 12:00 CET today.

IDEX Biometrics ASA's first quarter 2025 report is attached to this notice. Recent highlights: On 11 March 2025 IDEX Biometrics announced a new strategy with a fundamental shift in how the company would take its unique technology and products to market New CEO appointed – Anders Storbråten Securing a new debt facility of NOK 30 million, converted to shares Heights convertible bond renegotiated and amended Range of operational improvement initiatives under way – target quarterly run rate OPEX from end Q3 2025 in the range of $1.5-1.7 million.

Reference is made to the stock exchange announcements issued by IDEX Biometrics ASA (the "Company") on 11 March and 11 April 2025 regarding the successful loan financing of NOK 30 million and the subsequent conversion of such debt to shares in the Company at a subscription price of NOK 0.01 per share, resulting in the issuance of 3,000,000,000 new shares ("Debt Conversion” and “Debt Conversion Shares"), the subsequent offering of up to 600,000,000 new shares at a subscription price equal to the subscription price in the Debt Conversion ("Subsequent Offering" and the "Offer Shares"), and the amendment of a certain senior convertible bond (the "Convertible Bond") issued by an affiliate of Heights Capital Management ("Heights") to the Company, whereby, among other things, the principal amount of the Convertible Bond was reduced to an aggregate principal amount of NOK 49,980,000.

The Nomination Committee of IDEX Biometrics ASA proposes that Morten Opstad, Annika Olsson and Adriana Saitta, all current board members and European residents and nationals, form the new board of directors, with Morten Opstad serving as the Chair. The proposal is that they continue for a new term of two years.

I focus on anticipating market shifts, applying a big-picture, thematic approach to find alpha where others aren't looking. Despite market fragility and high valuations, I'm actively buying cyclical dividend growth stocks before broader sentiment turns positive. Early signs of economic improvement suggest cyclical sectors, especially industrials and transportation, offer exceptional long-term risk/reward.